"C\u00EDlem pr\u016F\u0159ezov\u00E9 studie bylo zjistit prevalenci kardiometabolick\u00FDch rizikov\u00FDch faktor\u016F ve vzorku \u010Desk\u00FDch pacient\u016F s onemocn\u011Bn\u00EDm schizofrenn\u00EDho okruhu a predikovat riziko \u010Dasn\u00E9 kardiovaskul\u00E1rn\u00ED mortality v t\u00E9to populaci. Byla zpracov\u00E1na data od 129 pacient\u016F veden\u00FDch v ambulanci pro l\u00E9\u010Dbu psych\u00F3z na Psych. klinice v Hradci Kr\u00E1lov\u00E9. Studovan\u00E9 prom\u011Bnn\u00E9 zahrnovaly z\u00E1kladn\u00ED t\u011Blesn\u00E9 parametry (v\u00FD\u0161ka, v\u00E1ha, obvod pasu, krevn\u00ED tlak), prevalenci kou\u0159en\u00ED, laboratorn\u00ED prom\u011Bnn\u00E9 (glyk\u00E9mie, lipidy v s\u00E9ru) a EKG. Dle v\u00FDsledk\u016F studie jsou nejv\u00EDce zastoupen\u00FDmi rizikov\u00FDmi faktory nadv\u00E1ha (70% pacient\u016F s BMI} 25), dyslipid\u00E9mie (70%) a kou\u0159en\u00ED (43%). Dle syst\u00E9mu SCORE bylo u 10% pacient\u016F p\u0159\u00EDtomno vysok\u00E9 riziko fat\u00E1ln\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody do deseti let. P\u0159i pou\u017Eit\u00ED Evropsk\u00FDch vod\u00EDtek pro prevenci kardiovaskul\u00E1rn\u00EDch nemoc\u00ED jsme nalezli vysok\u00E9 riziko u 24% nemocn\u00FDch. Tyto hodnoty jsou vysok\u00E9 i v porovn\u00E1n\u00ED se zahrani\u010Dn\u00ED literaturou a dokl\u00E1daj\u00ED vysokou kardiometabolickou morbiditu pacient\u016F s psych\u00F3zou."@cs . "FR - Francouzsk\u00E1 republika" . . "5"^^ . . "C\u00EDlem pr\u016F\u0159ezov\u00E9 studie bylo zjistit prevalenci kardiometabolick\u00FDch rizikov\u00FDch faktor\u016F ve vzorku \u010Desk\u00FDch pacient\u016F s onemocn\u011Bn\u00EDm schizofrenn\u00EDho okruhu a predikovat riziko \u010Dasn\u00E9 kardiovaskul\u00E1rn\u00ED mortality v t\u00E9to populaci. Byla zpracov\u00E1na data od 129 pacient\u016F veden\u00FDch v ambulanci pro l\u00E9\u010Dbu psych\u00F3z na Psych. klinice v Hradci Kr\u00E1lov\u00E9. Studovan\u00E9 prom\u011Bnn\u00E9 zahrnovaly z\u00E1kladn\u00ED t\u011Blesn\u00E9 parametry (v\u00FD\u0161ka, v\u00E1ha, obvod pasu, krevn\u00ED tlak), prevalenci kou\u0159en\u00ED, laboratorn\u00ED prom\u011Bnn\u00E9 (glyk\u00E9mie, lipidy v s\u00E9ru) a EKG. Dle v\u00FDsledk\u016F studie jsou nejv\u00EDce zastoupen\u00FDmi rizikov\u00FDmi faktory nadv\u00E1ha (70% pacient\u016F s BMI} 25), dyslipid\u00E9mie (70%) a kou\u0159en\u00ED (43%). Dle syst\u00E9mu SCORE bylo u 10% pacient\u016F p\u0159\u00EDtomno vysok\u00E9 riziko fat\u00E1ln\u00ED kardiovaskul\u00E1rn\u00ED p\u0159\u00EDhody do deseti let. P\u0159i pou\u017Eit\u00ED Evropsk\u00FDch vod\u00EDtek pro prevenci kardiovaskul\u00E1rn\u00EDch nemoc\u00ED jsme nalezli vysok\u00E9 riziko u 24% nemocn\u00FDch. Tyto hodnoty jsou vysok\u00E9 i v porovn\u00E1n\u00ED se zahrani\u010Dn\u00ED literaturou a dokl\u00E1daj\u00ED vysokou kardiometabolickou morbiditu pacient\u016F s psych\u00F3zou." . . . . "Z(MSM0021620816), Z(MZ0FNHK2005)" . "Kardiometabolick\u00E9 riziko u nemocn\u00FDch schizofreni\u00ED"@cs . "5"^^ . "1211-7579" . . "Ba\u017Eant, Jan" . . "RIV/00179906:_____/10:10051735" . . "5"^^ . "4" . "Cardiometabolic Risk in Patients with Schizophrenia"@en . . . . "266117" . . . "Psychiatrie" . "The aim of this cross-sectional study was to assess the prevalence of cardiometabolic risk factors in a sample of Czech patients with schizophrenia and related diseases and to predict their risk of premature cardiovascular mortality. We reviewed data from 129 outpatients treated in the clinic for psychoses. The main collected variables included physical parameters (height, weight, waist circumference, blood pressure), smoking habits, laboratory data (glucose, serum lipids) and ECG. Our results show that the most prevalent risk factors are overweight (70% of patients have BMI over 25), dyslipidaemia (70%) and smoking (43%). According to SCORE diagram, there is a high risk of fatal cardiovascular event in ten years in 10% of patients. The percentage gets even higher (24%) when the latest European guidelines for cardiovascular disease prevention were used to calculate the risk. Our outcomes indicate even higher cardiometabolic morbidity in patients with psychoses than referred in literature."@en . . "Mal\u00FD, Radovan" . "[975142E1CFAC]" . "Kardiometabolick\u00E9 riziko u nemocn\u00FDch schizofreni\u00ED" . "Konup\u010D\u00EDkov\u00E1, Kate\u0159ina" . "Kardiometabolick\u00E9 riziko u nemocn\u00FDch schizofreni\u00ED" . . "Kardiometabolick\u00E9 riziko u nemocn\u00FDch schizofreni\u00ED"@cs . "RIV/00179906:_____/10:10051735!RIV11-MZ0-00179906" . . . . "Cardiometabolic Risk in Patients with Schizophrenia"@en . . "14" . . "cardiovascular morbidity; antipsychotic drugs; schizophrenia; Cardiology"@en . "Kalnick\u00E1, Dita" . "Masopust, Ji\u0159\u00ED" . .